Advertisement

TMU-KMU medical tech business matchmaking event spurs industry-academia communication

tmu-kmu medical tech business matchmaking event spurs industry-academia communication

BEGIN ARTICLE PREVIEW:

TMU-KMU medical tech business matchmaking event spurs industry-academia communication
Taiwan maintains a leading edge in medical technologies with a myriad of academic research teams working on projects producing valuable achievements. However, these achievements have remained hidden inside universities. To help promote the development of premium-quality medical supplies and technologies and drive commercialization of academic research results, Taipei Medical University (TMU) and Kaohsiung Medical University (KMU) co-hosted the “TMU x KMU Joint Medical Technology Business Matchmaking” event on September 29, 2020. Bringing together Taiwan’s entrepreneurs and startup teams, the event built a bridge for industry-academia communication.Six teams with development potential presented their products and technology strength and discussed with the guests with respect to the feasibility of marketing their research results.In his speech, TMU vice president Chieh-Hsi Wu noted matchmaking events are of great significance to both TMU and KMU. Faculty members at the two medical universities have long been committed to advanced medical technology research and have built up a solid foundation. However, they lack the industry connections to help bring their research achievements to commercialization. This is exactly the purpose of the matchmaking event – turning the research energy that has been accumulated over the years into viable business …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “TMU-KMU medical tech business matchmaking event spurs industry-academia communication”

Health Wildcatters Co-Founder and CEO Hubert Zajicek To Receive 2020 Dennis K. Stone Award

health wildcatters co-founder and ceo hubert zajicek to receive 2020 dennis k. stone award

BEGIN ARTICLE PREVIEW:

Health Wildcatters co-founder and CEO Hubert Zajicek [Image: Courtesy Health Wildcatters]
At this year’s Sixth Annual iC3 Life Sciences Summit, investment and innovation catalyst Dr. Hubert Zajicek will be presented with the 2020 Dennis K. Stone Award.
Zajicek, who is a co-founder, partner, and CEO of Health Wildcatters, is being honored by the Bio North Texas Foundation because he has positively affected quality of life by raising life science research awareness and funds, impacted innovation to bring discoveries to commercial relevance, and gave back to his community and those in the scientific field, according to a statement.
“Dr. Zajicek’s focus on providing mentorship, capital, and guidance to early stage healthcare companies has directly contributed to North Texas being recognized internationally for its growing life sciences industry,” Bio North Texas CEO Jorge Varela said in a statement.
Zajicek is most known for his work through Health Wildcatters, a Dallas-based seed stage healthcare fund and accelerator. The organization has invested in over 70 healthcare startups to date, which have attracted over $100 million in capital, according to a statement.
“His efforts have resulted in companies and talent relocating to this area and in significant startup funding,” Varela said.
Earlier this year, Zajicek launched …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Health Wildcatters Co-Founder and CEO Hubert Zajicek To Receive 2020 Dennis K. Stone Award”

3M slightly down despite Street-beating Q3 | Medical Design and Outsourcing

3m slightly down despite street-beating q3 | medical design and outsourcing

BEGIN ARTICLE PREVIEW:

3M (NYSE:MMM) shares took a slight dip today on third-quarter results that finished ahead of the consensus forecast.The St. Paul, Minn.-based company posted profits of $1.4 billion, or $2.43 per share, on sales of $8.4 billion for the three months ended Sept. 30, 2020, for a -10.7% bottom-line slide on sales growth of 4.5%.
Adjusted to exclude one-time items, earnings per share were also $2.43, 17¢ ahead of Wall Street, where analysts were looking for sales of $8.3 billion.
Get the full story on our sister site, MassDevice.

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “3M slightly down despite Street-beating Q3 | Medical Design and Outsourcing”

Inspire Medical Systems, Inc. to Present at the Credit Suisse 29th Annual Healthcare Conference

inspire medical systems, inc. to present at the credit suisse 29th annual healthcare conference

BEGIN ARTICLE PREVIEW:

South China Morning PostWhat is Jack Ma’s Ant Group and how does it make money?Digital financial services giant Ant Group is on the cusp of pulling off the world’s biggest initial public offering and could be worth over US$500 billion in the near future, riding on the digitisation of financial services in the world’s second-largest economy.Hangzhou-headquartered Ant’s coming out parade illustrates China’s lead in digital finance. Its super-slick mobile payment app, Alipay, has over 1 billion users, making it the world’s most popular app outside social-media networks.Ant’s payments network is just the gateway, funnelling small businesses and consumers into a broad financial ecosystem spanning lending, investment and insurance services.Get the latest insights and analysis from our Global Impact newsletter on the big stories originating in China.The world’s most valuable privately owned company is also developing services to make daily life easier. Consumers can click on the Alipay app for services ranging from food deliveries to garbage collection.The system’s cogs are oiled by a trove of data gathered in China, the world’s most populous country, which makes pricing more accurate and efficient than at traditional banks.Ant plans to plough the US$34.5 billion it is raising …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Inspire Medical Systems, Inc. to Present at the Credit Suisse 29th Annual Healthcare Conference”

Global Enteral Feeding Devices Market 2020-2026: Focus on Feeding Pumps, PEG/J Kits, Low-Profile Devices, Gastrointestinal Tubes, Nasointestinal Tubes, Giving/Extension Sets

global enteral feeding devices market 2020-2026: focus on feeding pumps, peg/j kits, low-profile devices, gastrointestinal tubes, nasointestinal tubes, giving/extension sets

BEGIN ARTICLE PREVIEW:

DUBLIN, Oct. 27, 2020 /PRNewswire/ — The “Enteral Feeding Devices – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering.
The report reviews, analyzes and projects the global Enteral Feeding Devices market for the period 2017-2026 in terms of Units and US$ and the compound annual growth rates (CAGRs) projected from 2019 through 2026 with a special focus y-o-y for 2019 and 2020.The impact of COVID-19 pandemic on global enteral feeding devices market is expected to differ in intensity depending on the device type. Sharpest declines would be expected in demand for PEG/J Kits, Low-Profile Devices and Gastrointestinal Tubes, due to cancelled or delayed elective procedures and delays in tube replacements. On the other hand, demand for Feeding Pumps, Nasointestinal Tubes and Giving/Extension Sets is forecast to witness robust gains during 2019-2020, due to the extra demand created from COVID-19 related ICU admissions.Demand for Feeding Pumps across the globe is expected to record a robust y-o-y growth of over 14% in terms of both volume and value in 2020, followed by Giving/Extension Sets and Nasointestinal Tubes. The overall global market for Enteral Feeding Devices is expected to exceed 100 million by 2026.
Research Findings & Coverage

This global market research report on Enteral …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Global Enteral Feeding Devices Market 2020-2026: Focus on Feeding Pumps, PEG/J Kits, Low-Profile Devices, Gastrointestinal Tubes, Nasointestinal Tubes, Giving/Extension Sets”

ABM Respiratory Care Raises US$10.3M in Series A Funding Round and Appoints Peter H. Soderberg as Chairman of the Board of Directors

abm respiratory care raises us$10.3m in series a funding round and appoints peter h. soderberg as chairman of the board of directors

BEGIN ARTICLE PREVIEW:

SINGAPORE, Oct. 27, 2020 /PRNewswire/ — ABM Respiratory Care, a medical device company focused on developing novel integrated airway clearance and ventilation solutions, announced today the raise of US$10.3M in its series A funding round led by Advanced MedTech Holdings, a global medical technology leader, and SEEDS Capital, the investment arm of Enterprise Singapore. The funding will help ABM advance their US commercialization plans.
ABM Respiratory Care also announced the appointment of Peter H. Soderberg as Chairman of the company’s Board of Directors.  Mr. Soderberg currently serves as the Chairman of the Board of Directors for Tactile Medical, a publicly traded medical device company. Mr. Soderberg recently concluded 18 years of service on the board of directors of Integer Holdings Corp. (formerly Greatbatch, Inc.), a medical technology company. Mr. Soderberg previously served on the boards of Constellation Brands, Inc. and the Advanced Medical Technology Association. In addition Mr. Soderberg is currently the Managing Partner of Worthy Venture Resources, LLC, a company focused on growing commercial stage companies to a global market presence. Before his semi-retirement in 2010, he served as President and Chief Executive Officer of Hillenbrand Industries and Hill-Rom, and, before that, of Welch Allyn. He has previously held executive positions at …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “ABM Respiratory Care Raises US$10.3M in Series A Funding Round and Appoints Peter H. Soderberg as Chairman of the Board of Directors”

Concord Health Partners Names Tim Leahy a Partner

concord health partners names tim leahy a partner

BEGIN ARTICLE PREVIEW:

SUMMIT, N.J., Oct. 27, 2020 /PRNewswire/ — Concord Health Partners, a healthcare focused investment firm, today announced that Timothy Leahy has been promoted to Partner.  Mr. Leahy joined Concord in 2019 and has more than 20 years of healthcare industry investment experience. 
“Tim has been an invaluable member of the Concord Investment Team, and we are exceptionally pleased to announce this well-deserved promotion,” said James Olsen Founder & Managing Partner at Concord.  “As we continue to expand the platform and execute on our strategy, Tim will be instrumental in helping to identify promising new portfolio companies, support management teams and drive growth to create value for all key stakeholders.”
Mr. Leahy joins James Olsen, Joe Swedish, Benson Jose and Vin Ferrara, MD as Partners at Concord.   He serves on the Investment Committee and maintains Board roles with two portfolio companies, Loyal and Bright.md.  Mr. Leahy played a key role in an investment in Cedar and he supports CHP Merger Corp, a healthcare SPAC sponsored by Concord.
Prior to joining Concord, Mr. Leahy served as a Managing Director at BelHealth Investment Partners, a healthcare focused buyout firm, where he focused on originating, structuring, and executing private equity transactions in healthcare services, specifically in the …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Concord Health Partners Names Tim Leahy a Partner”

The HydraFacial® Company Partners with Circadia

the hydrafacial® company partners with circadia

BEGIN ARTICLE PREVIEW:

LONG BEACH, Calif., Oct. 27, 2020 /PRNewswire/ — The HydraFacial™ Company announced they have extended their partnership globally, offering the Chrono-Peptide Booster and ProTec Plus Booster to HydraFacial providers in over 40 countries.
HydraFacial boosters allow consumers to tailor their treatment with award-winning super serums to address specific skin concerns. Circadia’s ChronoPeptide Booster was designed to rebuild the skin through innovative peptide technology that targets fine lines, age spots, wrinkles, texture and imperfections; the ProTec Plus Booster was designed to instantly plump and smooth fine lines and wrinkles while drenching the skin in ultimate hydration.
“The Circadia boosters for HydraFacial are already loved by providers and consumers alike here in the US, and we are excited to expand our partnership globally,” said Clint Carnell, Chief Executive Office of The HydraFacial Company.  “Combining the powerful skin care offerings of Circadia with our innovative technologies allows HydraFacial providers the opportunity to customize their treatments for even more skin types.”
HydraFacial is an innovative beauty health company with 30 patents, and 24 patents pending. The award-winning HydraFacial system merges invigorating spa therapies with advanced medical technology, offering personalized skin solutions. HydraFacial is an advanced non-laser skincare system offering a customizable procedure for all faces, improving the appearance of …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “The HydraFacial® Company Partners with Circadia”

Imbio Partners with Siemens Healthineers to Deliver Image Analysis Tools to Clinicians Across the Globe

imbio partners with siemens healthineers to deliver image analysis tools to clinicians across the globe

BEGIN ARTICLE PREVIEW:

MINNEAPOLIS, Oct. 27, 2020 /PRNewswire/ — Imbio, a healthcare technology company developing the leading suite of medical image analysis for pulmonary and cardiothoracic diseases, and Siemens Healthineers, a leading medical technology company, announced they are partnering to expand access to Imbio AI algorithms worldwide. Physicians will now be able to apply Imbio’s automated AI for quantitative image analysis directly through the Open Apps interface on Siemens’ syngo.via platform.
Imbio provides quantitative and personalized imaging analysis for patients suffering from both acute and chronic diseases. Imbio’s fully automated technology transforms chest CT studies into rich visual maps of a patient’s lungs with accompanying reports that provide detailed data on the type and extent of abnormalities found in the images. For example, with Imbio Lung Density Analysis™ and Lung Texture Analysis™ clinicians can quickly visualize a patient’s lungs to support diagnosis and treatment decisions for a variety of patient conditions including COPD/emphysema and fibrotic disease. Imbio products support multiple clinical initiatives such as lung cancer screening, smoking cessation and pulmonary embolism management programs, and can be used in clinical trials and academic research for numerous diseases.
“Delivering our AI solutions requires a reliable and trusted platform like syngo.via. Together with Siemens, …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE Continue reading “Imbio Partners with Siemens Healthineers to Deliver Image Analysis Tools to Clinicians Across the Globe”